Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Public Health

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Tuberculosis lymphadenitis in Southwest Ethiopia: a community based cross-sectional study

  • Gemeda Abebe1, 8Email author,
  • Amare Deribew2, 8,
  • Ludwig Apers3,
  • Alemseged Abdissa1,
  • Fetene Deribie1,
  • Kifle Woldemichael2,
  • Jaffer Shiffa4,
  • Markos Tesfaye5,
  • Chali Jira6,
  • Mesele Bezabih1,
  • Abraham Aseffa7,
  • Alemayehu Bekele1 and
  • Robert Colebunders3, 8
BMC Public Health201212:504

https://doi.org/10.1186/1471-2458-12-504

Received: 19 February 2012

Accepted: 6 July 2012

Published: 6 July 2012

Abstract

Background

In Ethiopia where there is no strong surveillance system and diagnostic facilities are limited, the real burden of tuberculosis (TB) lymphadenitis is not well known. Therefore, we conducted a study to estimate the prevalence of TB lymphadenitis in Southwest Ethiopia.

Methods

A community based cross-sectional study was conducted from February to March 2009 in the Gilgel Gibe field research area. A total of 30,040 individuals 15 years or older in 10,882 households were screened for TB lymphadenitis. Any individual 15 years or older with lumps in the neck, armpits or groin up on interview were considered TB lymphadenitis suspect. The diagnosis of TB lymphadenitis was established when acid fast bacilli (AFB) smear microscopy of fine needle aspiration (FNA) sample, culture or cytology suggested TB. HIV counseling and testing was offered to all TB lymphadenitis suspects. Descriptive and bivariate analysis was done using SPSS version 15.

Results

Complete data were available for 27,597 individuals. A total of 87 TB lymphadenitis suspects were identified. Most of the TB lymphadenitis suspects were females (72.4%). Sixteen cases of TB lymphadenitis were confirmed. The prevalence of TB lymphadenitis was thus 58.0 per 100,000 people (16/27,597) (95% CI 35.7-94.2). Individuals who had a contact history with chronic coughers (OR 5.58, 95% CI 1.23-25.43) were more likely to have TB lymphadenitis. Lymph nodes with caseous FNA were more likely to be positive for TB lymphadenitis (OR 5.46, 95% CI 1.69-17.61).

Conclusion

The prevalence of TB lymphadenitis in Gilgel Gibe is similar with the WHO estimates for Ethiopia. Screening of TB lymphadenitis particularly for family members who have contact with chronic coughers is recommended. Health extension workers could be trained to screen and refer TB lymphadenitis suspects using simple methods.

Keywords

TB lymphadenitisPrevalenceJimmaEthiopia

Background

TB lymphadenitis is the most common form of extrapulmonary TB [1]. Its epidemiology and diagnostic aspects vary according to the patients’ geographic origin and the burden of TB and HIV infection [2]. Globally the incidence of all forms of TB is decreasing. However, the rate is not similar across all WHO regions. In the Africa region it is decreasing slowly by 1.8% per year [3].

Ethiopia is among the 22 high TB burden countries in the world. The proportion of extrapulmonary TB among newly diagnosed TB patients has been increasing for the last two decades [3]. The WHO and the Ethiopian TB control program estimate that the proportion of extrapulmonary TB among the total number of new TB cases (156,928) is about 32% [4, 5]. The majority of extrapulmonary TB cases present with TB lymphadenitis. However, the real burden of pulmonary TB and extrapulmonary TB in Ethiopia is not known at community level. The lack of diagnostic facilities and low quality health services might contribute to low case detection rates [6]. In the absence of a strong surveillance system and well established diagnostic facilities, community-based prevalence studies are good alternatives to estimate the burden of disease. We performed such a study in Southwest Ethiopia to estimate the burden of TB lymphadenitis. To our knowledge, this is the first community-based prevalence survey for TB lymphadenitis in Ethiopia.

Methods

Study design, setting and period

This community-based cross sectional study was conducted from February to March 2009 in Gilgel Gibe Field Research area (Figure 1) which is located in Jimma Zone about 260 kilometers Southwest of Addis Ababa around the reservoir of Gilgel Gibe hydroelectric dam. The site consists of four districts (locally known as Woredas): Sokoru, Omo Nada, Tiro Afata and Qarsa. Two small towns and eight rural Kebeles (smallest administrative units), situated within 10 kilometers of the reservoir of the dam were selected as field research site by Jimma University in 2005. Since then, regular demographic and AIDS mortality surveillances have been undertaken by Jimma University in the research site. At the time of the study, the total population of the field research area was 50,156 individuals in 10,882 households.
Figure 1

Map of Gilgel Gibe filed research area.

Study population and data collection procedures

At the time of the study the total number of individuals 15 years or older in the study area was 30,040. A questionnaire was prepared in Amharic (local language) to identify TB lymphadenitis suspects in the study area. Trained personnel with high school education visited each household. If the heads of the households were not available during the visit, the data collectors repeatedly visited the same household up to 3 times. Individuals were asked if they had noticed lumps and bumps in the neck, armpits or groin themselves. Only those that respond positively were considered suspects and asked to come the next day to a center to undergo FNA. At the center those TB lymphadenitis suspects were interviewed using a structured questionnaire including questions about his/her socio-demographic situation.

Sample collection and processing

The FNA was performed by the study pathologists. The diagnosis of TB lymphadenitis was made when smear microscopy, culture and/or cytology suggested TB individually or in combination.

FNA

FNA was performed using a 22-gauge needle attached to a 10-cc syringe. The aspirates were macroscopically evaluated for caseation. Two smears were prepared from each aspirate and air dried on site. The remainder of the aspirate was washed into 1 ml physiological saline for culture and transported to Jimma University Specialized Hospital in a cold box. FNA samples were kept at −20°C till transported in cold box by postal system to Armauer Hansen Research Institute (AHRI) in Addis Ababa for culture. All samples were transported within a maximum of 5 days.

One slide of a smear was stained with the Ziehl-Neelsen method [7] and examined for the presence of AFB by an experienced laboratory technician. The second smear was stained with Wright stain and cytological analysis was done by the study pathologists at Jimma University. TB lymphadenitis diagnosis by cytology was made by observation of the presence of epitheloid cell granulomas and caseous necrosis with or without Langhan’s giant cells [8, 9].

Culture

At the AHRI, the FNA samples were processed by the standard N-acetyl L-cysteine (NALC)-NaOH method [10] and concentrated at 3000 × g for 15 minutes. The sediment was reconstituted to 2.5 ml with phosphate buffer pH 6.8, to make the inoculums for the cultures. Two Lowenstein-Jensen slants, one containing 0.75% glycerol and the other containing 0.6% pyruvate, were inoculated with the sediment and incubated at 37°C. Cultures were considered negative when no colonies were seen after 8 weeks of incubation.

HIV Screening

All consenting TB lymphadenitis suspects were tested for HIV after counseling. Testing for HIV was done as per Ethiopian national guidelines. HIV screening was performed using the KHB test (Shanghai Kehua Bio-Engineering Ltd, Shanghai, China; 2008). A positive sample was retested using the STAT-PAK test (Chembio Diagnostic System Inc, Medford, NY, USA; 2008).

Data analysis

Data were double entered using Epi-data version 3.1(Epi-data, Norway, 2006). For analysis, the data were exported to SPSS version 15.0 statistical software (SPSS Inc. Chicago, 2007). Descriptive analysis was done for the socio-demographic variables and prevalence of TB lymphadenitis. Logistic regression was done to assess factors independently associated with TB lymphadenitis in terms of the crude odds ratio and its 95% confidence interval (CI). A p-value less than or equal to 0.05 was considered significant.

Ethical consideration

The study was approved by the ethical review committees of Jimma University, AHRI and the Institute of Tropical Medicine in Belgium. A workshop was held with the local community leaders, Kebele chair persons and Woreda health offices representatives to create awareness about the purpose of the study. Written consent was obtained from the study participants. First the head of the house gave consent. Subsequently depending on the information from the head of the house all the suspects gave consent before administering the questionnaire and undergoing FNA. New TB cases identified were immediately referred to the nearby health facility for treatment.

Results

Characteristics of the TB lymphadenitis suspects

A total of 30,040 individuals 15 years or older in 10,882 households were screened for TB lymphadenitis. Complete data were available from 9 Kelebes (27,597 individuals 15 years or older) while one Kebele was excluded from analysis because of incomplete data. After interview 87 TB lymphadenitis suspects were identified. The mean age (±SD) of the suspects was 33.1 (±11.3) years. Most (72.4%) were women and married (81.6%). Thirty one (35.6%) lived in close contact with animals and 45 (53.5%) used to drink raw milk.

Prevalence of TB Lymphadenitis

On the basis of FNA smear microscopy for AFB, cytology and culture 16 (18.4%) of the lymph nodes were diagnosed as tuberculous. Smears were positive in 2, culture in 6 and cytology in 13 of the suspects. The microscopic features of FNA cytology of the TB lymphadenitis showed epithelial histocytes with giant cells in 8 cases, epithelial histocytes with caseous necrosis in 2 cases and caseous necrosis alone in 3 cases. Three of these 16 cases were positive by both culture and FNA cytology. The mycobacteria isolated in 6 cases were identified as Mycobacterium tuberculosis based on RD typing. The remaining 10 cases that were negative on culture but positive on smear and/or cytomorphology were also considered to be tuberculous. The distribution of TB lymphadenitis cases per kebele is indicated in Table 1. The prevalence of TB lymphadenitis was 58.0 per 100,000 people (16/27,597) (95% CI 35.7-94.2). Other diagnosis of the lymph nodes include: reactive lymphadenitis (57), pyogenic lymphadenitis (6), benign mesenchymal neoplasia (6) and non-specific lymphadenitis (5).
Table 1

Distribution of TB lymphadenitis cases in the study Kebeles of Gilgel Gibe Field Research Center, Southwest Ethiopia

Kebele

Total population surveyed

TB lymphadenitis

95% CI

n (prevalence per 100,000 people)

Siba

2893

1 (34.6)

6.1-195.5

Asandabo

4493

0 (0)

0-85.4

Burka

3539

1 (28.3)

5.0-159.9

Kajelo

3409

2 (58.7)

16.1-213.7

Koticha

2342

1 (42.7)

7.5-241.5

Ayino

3382

2 (59.1)

16.2-215.4

Enkure

2048

3 (146.5)

49.8-429.8

Bore

2065

0 (0)

0-185.7

Danaba

3426

6 (175.1)

80.3-381.6

CI Confidence interval.

Epidemiological factors associated with TB lymphadenitis

TB lymphadenitis was more frequent in females (86.5 per 100,000) and age group 35–44 (90.4 per 100,000 people) followed by 45 years or older (71.9 per 100,000 people). The differences in the prevalence of TB lymphadenitis with respect to sex and age group were not statistically significant (Table 2). Other personal characteristics associated with TB lymphadenitis are described in Table 3. Only contact with a person with chronic cough was significantly associated with TB lymphadenitis (OR 5.58, 95% CI 1.23-25.43).
Table 2

Prevalence of lymphadenopathy and tuberculous lymphadenitis per 100,000 people by sex and age in Gilegl Gibe, south west Ethiopia

Variable

Total population

Lymphadenopathy n(prevalence)

TB Lymphadenitis n (prevalence)

OR [95% CI]

Sex

    

Male

13718

24 (174.9)

4 (29.2)

1

Female

13879

63 (453.9)

12 (86.5)

2.97 [0.97- 9.20]

Age

    

15-24

10482

16 (152.6)

3 (28.6)

1

25-34

7129

30 (420.8)

5 (70.1)

3.43 [0.89- 13.28]

35-44

4423

28 (633.1)

4 (90.4)

2.37 [0.48- 11.75]

> = 45

5563

13 (233.7)

4 (71.9)

1.89 [0.38- 9.34]

OR Odds ratio, CI Confidence interval.

Table 3

Characteristics of persons with tuberculous and non-tuberculous lymphadenitis, Gilgel Gibe, southwest Ethiopia

Characteristics of persons

TB status

 

OR [95% CI]

 

Positive n (%)

Negative n (%)

 

Sex

Male

4 (16.7)

20 (83.3)

1.18 [0.34-4.1]

Female

12 (19.0)

51 (81.0)

1

Age

15-24

3 (18.8)

13 (81.2)

1

25-34

5 (16.7)

25 (83.3)

0.87 [0.18-4.21]

35-44

4 (14.3)

24 (85.7)

0.72 [0.14-3.73]

> = 45

4 (30.8)

9 (69.2)

1.93 [0.34-10.77]

Occupation

Farmer

11 (19.6)

45 (80.4)

0.69 [0.40- 4.06]

Non-farmer

5 (16.1)

26 (83.9)

1

Monthly income

<=400 birr (<=34 USD)

10 (21.3)

37 (78.7)

1.35 [0.14- 12.92]

>400 birr (>34 USD)

1 (16.7)

5 (83.3)

1

Contact with a chronic cougher

Yes

4 (50.0)

4 (50.0)

5.58 [1.23- 25.43]*

No

12 (15.2)

67 (84.8)

1

Contact with cattle

Yes

6 (19.4)

25 (80.6)

1.10 [0.36- 3.39]

No

10 (17.9)

46 (82.10)

1

Drink uncooked milk

Yes

10 (21.3)

37 (78.7)

1.53 [0.50- 4.67]

No

6 (15.0)

34 (85.0)

1

OR Odds ratio, CI Confidence interval, USD United Sates Dollar, *p < 0.05.

Characteristics of the lymph nodes associated with TB lymphadenitis

Lypmh node characteristics affecting positivity for tuberculous lymphadenitis are described in Table 4. Among the lymph nodes characteristics only caseous FNA samples were more likely to be from persons with TB lymphadenitis (OR 5.46, 95% CI 1.69-17.61).
Table 4

Characteristics of the lymph nodes in persons with tuberculous and non-tuberculous lymphadenitis, Gilgel Gibe, southwest Ethiopia

Characteristic of the lymph node

TB status

 

OR [95% CI]

 

Positive n (%)

Negative n (%)

 

Duration

<=6 weeks

8 (25.0)

24 (75.0)

2.28 [0.71- 7.36]

7-12 weeks

2 (25.0)

6 (75.0)

2.28 [0.37- 14.0]

>12 weeks

6 (12.8)

41 (87.2)

1

Tenderness

Tender

2 (18.2)

9 (81.8)

0.98 [0.19- 5.07]

Non-tender

14 (18.4)

62 (81.6)

1

Number of lymph nodes

Single

5 (12.2)

36 (87.80)

1

Few

2 (20.0)

8 (80.0)

1.80 [0.30- 11.0]

Multiple

9 (25.0)

27 (75.0)

2.40 [0.72- 8.0]

Size

1-4 cm

11 (15.5)

60 (84.5)

1

5-10 cm

5 (31.2)

11 (68.8)

2.48 [0.30- 11.0]

Mobility

Mobile

15 (21.4)

55 (78.6)

1

Non-mobile

1 (5.9)

16 (94.1)

0.23 [0.03- 1.87]

Condition

Soft

4 (17.4)

19 (82.6)

 

Firm

10 (16.9)

49 (83.1)

 

Matted

2 (66.7)

1 (33.3)

 

Draining sinus

0 (0.0)

1 (100.0)

 

Fluctuant

0 (0.0)

1 (100.0)

 
 

Lymph node involved

Cervical

12 (18.5)

53 (81.5)

1

Axiliary

3 (27.3)

8 (72.7)

1.66 [0.38- 7.19]

Inguinal

1 (11.1)

8 (88.9)

0.55 [0.06- 4.84]

Others

0 (0.0)

2 (100.0)

 

Nature of FNA specimen

Caseous

8 (42.1)

11 (57.9)

1

Non-caseous

8 (11.8)

60 (88.2)

5.46 [1.69- 7.61]*

OR Odds ratio, CI Confidence interval, *p < 0.05.

Discussion

Extrapulmonary TB is a significant health problem worldwide because of difficulties in its diagnosis and in monitoring its treatment. The proportion of extrapulmonary TB among all TB cases varies from country to country. Of the 22 high burden countries the highest proportion was reported from Cambodia (34.2%) and the lowest from China (0.69%) [5]. The extrapulmonary manifestation of TB is prevalent in 10-34% of non-HIV cases while it occurs in 50-70% of patients co-infected with HIV [11]. Ethiopia reports the third highest number of extrapulmonary TB globally (50,417) [5]. In the current study, we assessed TB lymphadenitis, the major form of extrapulmonary TB, in a rural community in Ethiopia.

In this study the diagnosis of TB lymphadenitis was established when FNA smear microscopy for AFB, culture and/or cytology reported positive. In fact cytology suffers from low number of cells that are all in dispersion rather than organized tissue as in biopsies. Nevertheless, cytology is specific when compared against combined criteria [3].

The prevalence of pulmonary TB was 76.1 per 100,000 people in the same study population during the same study period [12]. It is higher than the prevalence of TB lymphadenitis as reported here. TB lymphadenitis accounted for 43.2% (95%CI: 28.7-59.1) of all forms of TB diagnosed in the study setting. A previous report from Ethiopia also indicated that TB lymphadenitis accounted for 40% of total TB cases in a rural health center [13]. WHO estimates for Ethiopia that extrapulmonary TB accounts for roughly one third of the new cases of TB in the country [5]. However, it is not possible to compare the findings from our study with the national figure of the WHO estimates because of two main reasons. First, the WHO data were derived from health institution based reports. Second, our study did not investigate all forms of extrapulmonary TB. Investigating the different parameters to identify risk factors for TB lymphadenitis in areas of high and low proportions in the country is recommended.

It has been reported that TB case detection remains very low in Ethiopia [14]. Indeed, in our study all the TB lymphadenitis cases were newly diagnosed. The efforts to improve TB case detection in the country should be strengthened. It is logical that the health care seeking behavior could be low for TB lymphadenitis compared with that of pulmonary TB. This is mainly because pulmonary TB has a higher case fatality rate than TB lymphadenitis and the latter is mainly of cosmetic concern at least initially, which takes lower priority in rural communities with poor access to health facilities. Nevertheless, the health extension workers should be trained to identify not only pulmonary but also extrapulmonary TB suspects in the community and link them to health facilities.

A contact history with a chronic cougher was highly related with the odds of having TB lymphadenitis. This partly indicates that there is transmission going on in the community although further study may be needed to unravel the transmission dynamics. Moreover, this might indicate that the route of acquisition of lymph node TB is probably the same as pulmonary and can partly explain why Mycobacterium bovis was not detected. Other studies have reported a predominance of Mycobacterium tuberculosis in TB lymphadenitis in Ethiopia [15, 16] although bovine transmission would be expected where raw milk is consumed.

Cervical lymph nodes were the prominent sites involved in our study supporting previous reports [1719]. Studies have reported that women were more likely to be positive for TB lymphadenitis compared with men [2025]. Moreover, it has been suggested that in male dominated communities, where women experience poorer living conditions, young females generally notice differences in their appearance earlier than males [26]. In our study, however, the rate of TB lymphadenitis was not significantly different between the two sexes. Our previous finding from the study area on health seeking behavior also did not find a difference in gender [27]. The age group 35–44 years and FNA samples from axillary lymph nodes has shown the largest proportion of cases but difference in prevalence in terms of age group and location of the lymphnodes was not statistically significant.

Previous studies have suggested that the extrapulmonary forms of TB could be attributed to HIV co infection [18, 28]. In Ethiopia the HIV prevalence for rural areas was estimated to be 0.9% [29]. However, in our case all the TB suspects were HIV negative. This suggests that apart from HIV either mycobacterial strains or host factors may play an important role in TB lymphadenitis in this community. Recent reports elsewhere identified that single nucleotide polymorphisms rs4893980 on gene PDE11A of chromosome number 2, rs10488286 on gene KCND2 of chromosome number 7 and rs2026414 on gene PCDH15 of chromosome number 10 in humans were associated with extrapulmonary tuberculosis [30]. In this study we did not do the typing for host genetic factors predisposing for TB lymphadenitis.

The strength of our study was that it has tried to address the neglected component of TB at community level. However, our study was not without pitfalls. We probably underestimated the prevalence of tuberculous lymphadenopathies because individuals were not systematically examined for lymphadenopathies and culturing of the samples were delayed due to transport problems. Moreover, the methods that we used for the laboratory diagnosis of lymph node TB are not the most sensitive and specific. We did not use PCR which may have high sensitivity in detection of lymph node TB [31]. These all limitations in combination may have resulted in under estimation of the lymph node TB prevalence in communities living in Gilgel Gibe research site.

Conclusions

The prevalence of TB lymphadenitis was 58 per 100,000 people in Gilgel Gibe. Screening of TB lymphadenitis particularly for family members who have contact with chronic coughers is recommended. Health extension workers could be trained to screen and refer TB lymphadenitis suspects using simple methods.

Declarations

Acknowledgments

The authors appreciate the study participants for their cooperation in providing the necessary samples and information. The study was funded by the Directorate General for Development Cooperation (DGDC) through the Flemish Interuniversity Council (VLIR-UOS).

Authors’ Affiliations

(1)
Department of Medical Laboratory Sciences and Pathology, Jimma University
(2)
Department of Epidemiology, Jimma University
(3)
Department of Clinical Sciences, Institute of Tropical Medicine
(4)
Department of Internal Medicine, Jimma University
(5)
Department of Psychiatry, Jimma University
(6)
Department of Health Service Management, Jimma University
(7)
Armauer Hansen Research Institute
(8)
Department of Epidemiology and Social Medicine, University of Antwerp

References

  1. Ilgazli A, Boyaci H, Basyigit I, Yildiz F: Extrapulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases. Arch Med Res. 2004, 35: 435-441. 10.1016/j.arcmed.2004.05.008.View ArticlePubMedGoogle Scholar
  2. Weis SE, Moonan PK, Pogoda JM, Turk L, King B, Freeman-Thompson S, Burgess G: Tuberculosis in the foreign-born population of Tarrant county, Texas by immigration status. Am J Respir Crit Care Med. 2001, 164: 953-957.View ArticlePubMedGoogle Scholar
  3. Iwnetu R, van den Hombergh J, Woldeamanuel Y, Asfaw M, Gebrekirstos C, Negussie Y, Bekele T, Ashenafi S, Seyoum B, Melaku K, et al: Is tuberculous lymphadenitis over-diagnosed in Ethiopia? Comparative performance of diagnostic tests for mycobacterial lymphadenitis in a high-burden country. Scand J Infect Dis. 2009, 41: 462-468. 10.1080/00365540902897697.View ArticlePubMedGoogle Scholar
  4. Tesgaye F: Status of TB control programs in Ethiopia. Fifth National Tuberculosis Workshop. 2009, TRAC, JU, Jimma UniversityGoogle Scholar
  5. World Health Organization: WHO Report 2011: Global tuberculosis control 2011. 2011, World Health Organization, Geneva, -.Google Scholar
  6. Federal Ministry of Health Ethiopia: TB, leprosy and TB/HIV prevention and control program manual. 2007, , Addis Ababa, 4Google Scholar
  7. International Union Against Tuberculosis and Lung Disease: Sputum examination for tuberculosis by direct microscopy in low income countries. 2000, IUATLD, Paris, -. 5Google Scholar
  8. Verma K, Kapila K: Aspiration cytology for diagnosis of tuberculosis–perspectives in India. Indian J Pediatr. 2002, 69 (Suppl 1): S39-43.PubMedGoogle Scholar
  9. Bezabih M, Mariam DW: Determination of aetiology of superficial enlarged lymph nodes using fine needle aspiration cytology. East Afr Med J. 2003, 80: 559-563.PubMedGoogle Scholar
  10. Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, Mengoli C: Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol. 2004, 42: 2321-2325. 10.1128/JCM.42.5.2321-2325.2004.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Ozvaran MK, Baran R, Tor M, Dilek I, Demiryontar D, Arinc S, Toker N, Chousein EU, Sogukpinar O: Extrapulmonary tuberculosis in non-human immunodeficiency virus-infected adults in an endemic region. Ann Thorac Med. 2007, 2: 118-121. 10.4103/1817-1737.33700.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Deribew A, Abebe G, Apers L, Abdisa A, Deribe F, Woldemichael K, Jira C, Tesfaye M, Shiffa J, Assefa A, et al: Prevalence of pulmonary TB and spoligotype pattern of Mycobacterium tuberculosis among TB suspects in a rural community in Southwest Ethiopia. BMC Infect Dis. 2012, 12: 54-10.1186/1471-2334-12-54.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Yassin MA, Olobo JO, Kidane D, Negesse Y, Shimeles E, Tadesse A, Demissie A, Britton S, Harboe M, Aseffa A, Abate G: Diagnosis of tuberculous lymphadenitis in Butajira, rural Ethiopia. Scand J Infect Dis. 2003, 35: 240-243. 10.1080/00365540310004027.View ArticlePubMedGoogle Scholar
  14. Federal Ministry of Health of Ethiopia: Annual Health Service report. 2010, , Addis Ababa.Google Scholar
  15. Beyene D, Bergval I, Hailu E, Ashenafi S, Yamuah L, Aseffa A, Wiker HG, Engers H, Klatser P, Sviland L: Identification and genotyping of the etiological agent of tuberculous lymphadenitis in Ethiopia. J Infect Dev Ctries. 2009, 3: 412-419.View ArticlePubMedGoogle Scholar
  16. Tschopp R, Bobosha K, Aseffa A, Schelling E, Habtamu M, Iwnetu R, Hailu E, Firdessa R, Hussein J, Young D, Zinsstag J: Bovine tuberculosis at a cattle-small ruminant-human interface in Meskan, Gurage region, Central Ethiopia. BMC Infect Dis. 2011, 11: 318-10.1186/1471-2334-11-318.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Samaila M, Oluwole OP: Extrapulmonary tuberculosis: fine needle aspiration cytology diagnosis. Niger J Clin Pract. 2011, 14: 297-299. 10.4103/1119-3077.86771.View ArticlePubMedGoogle Scholar
  18. Geldmacher H, Taube C, Kroeger C, Magnussen H, Kirsten DK: Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest. 2002, 121: 1177-1182. 10.1378/chest.121.4.1177.View ArticlePubMedGoogle Scholar
  19. Morad NA: Tuberculous cervical lymphadenopathy: should antituberculous therapy be preceded by histological proof?. Trop Doct. 2000, 30: 18-20.PubMedGoogle Scholar
  20. Musellim B, Erturan S, Sonmez Duman E, Ongen G: Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation. Int J Tuberc Lung Dis. 2005, 9: 1220-1223.PubMedGoogle Scholar
  21. Sreeramareddy CT, Panduru KV, Verma SC, Joshi HS, Bates MN: Comparison of pulmonary and extrapulmonary tuberculosis in Nepal- a hospital-based retrospective study. BMC Infect Dis. 2008, 8: 8-10.1186/1471-2334-8-8.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Chandir S, Hussain H, Salahuddin N, Amir M, Ali F, Lotia I, Khan AJ: Extrapulmonary tuberculosis: a retrospective review of 194 cases at a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc. 2010, 60: 105-109.PubMedGoogle Scholar
  23. Ullah S, Shah SH, Aziz ur R, Kamal A, Begum N, Khan G: Extrapulmonary tuberculosis in Lady Reading Hospital Peshawar, NWFP, Pakistan: survey of biopsy results. J Ayub Med Coll Abbottabad. 2008, 20: 43-46.PubMedGoogle Scholar
  24. Garcia-Rodriguez JF, Alvarez-Diaz H, Lorenzo-Garcia MV, Marino-Callejo A, Fernandez-Rial A, Sesma-Sanchez P: Extrapulmonary tuberculosis: epidemiology and risk factors. Enferm Infecc Microbiol Clin. 2011, 29: 502-509. 10.1016/j.eimc.2011.03.005.View ArticlePubMedGoogle Scholar
  25. Forssbohm M, Zwahlen M, Loddenkemper R, Rieder HL: Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur Respir J. 2008, 31: 99-105. 10.1183/09031936.00020607.View ArticlePubMedGoogle Scholar
  26. Dandapat MC, Mishra BM, Dash SP, Kar PK: Peripheral lymph node tuberculosis: a review of 80 cases. Br J Surg. 1990, 77: 911-912. 10.1002/bjs.1800770823.View ArticlePubMedGoogle Scholar
  27. Abebe G, Deribew A, Apers L, Woldemichael K, Shiffa J, Tesfaye M, Abdissa A, Deribie F, Jira C, Bezabih M, et al: Knowledge, health seeking behavior and perceived stigma towards tuberculosis among tuberculosis suspects in a rural community in southwest Ethiopia. PLoS One. 2010, 5: e13339-10.1371/journal.pone.0013339.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Barnes PF, Lakey DL, Burman WJ: Tuberculosis in patients with HIV infection. Infect Dis Clin North Am. 2002, 16: 107-126. 10.1016/S0891-5520(03)00048-5.View ArticlePubMedGoogle Scholar
  29. Central Statistical Authority: Ethiopia Demographic and Health Survey 2005. 2006, Central Statistical Agency and ORC Macro, Addis Ababa EaC, 179-199.Google Scholar
  30. Oki NO, Motsinger-Reif AA, Antas PR, Levy S, Holland SM, Sterling TR: Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study. BMC Res Notes. 2011, 4: 28-10.1186/1756-0500-4-28.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Singh KK, Muralidhar M, Kumar A, Chattopadhyaya TK, Kapila K, Singh MK, Sharma SK, Jain NK, Tyagi JS: Comparison of in house polymerase chain reaction with conventional techniques for the detection of Mycobacterium tuberculosis DNA in granulomatous lymphadenopathy. J Clin Pathol. 2000, 53: 355-361. 10.1136/jcp.53.5.355.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/12/504/prepub

Copyright

© Abebe et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement